Flowserve Corporation (NYSE: FLS) - Deep Dive Research Report

Sector: Industrials | Listing: NYSE | Report date: 2026-06-13 Reporting cadence: Quarterly. Five most recent calls used: Q1 2025 (Apr 30 2025), Q2 2025 (Jul 30 2025), Q3 2025 (Oct 29 2025), Q4/FY 2025 (Feb 6 2026), Q1 2026 (May 9 2026). Most recent call is 35 days old, inside the 90-day window.

Section 1: What the Company Does

Flowserve makes the equipment that moves, controls, and contains liquids and gases inside heavy industrial plants. If you walk through an oil refinery, a chemical complex, a nuclear power station, or a desalination plant, the pumps pushing fluid through the pipes, the valves that throttle and shut off those flows, and the mechanical seals that stop hazardous fluids leaking out of rotating shafts are very often Flowserve's. The company describes itself as one of the world's largest manufacturers of pumps, valves, and seals, with around 16,000 employees in more than 50 countries.

The business has two distinct engines. One is selling the original equipment (OE) - the big engineered pumps, the severe-service valves, the seal systems that go into a new plant or a plant expansion. This is lumpy, project-driven, tied to customers' capital spending cycles, and competitively priced. The second engine, and the more important one for understanding why this company is interesting, is the aftermarket: once a Flowserve pump is bolted into a refinery, it runs for 20 to 40 years, and over that life it needs spare parts, repairs, seal replacements, upgrades, and servicing. Flowserve has an enormous installed base of equipment around the world, and that base throws off recurring, higher-margin aftermarket revenue. Aftermarket bookings have run above $600 million per quarter for eight consecutive quarters as of Q1 2026 (Q1 2026 call, May 9 2026). The company has a network of "Quick Response Centers" (QRCs) positioned near customer sites that can turn around critical spare parts and repairs fast - it advertises seal product orders within 72 hours of request - because in a refinery a single failed pump can shut down a whole production unit, and lost production costs far more than the part.

The core value proposition is reliability under brutal conditions. The fluids Flowserve's equipment handles are often hot, corrosive, abrasive, toxic, flammable, or all of those at once, at extreme pressures and temperatures. A pump moving crude slurry, or a valve isolating a high-pressure steam line in a nuclear reactor, cannot fail - failure means a fire, a toxic release, an environmental incident, or a multi-day plant shutdown. Customers therefore buy on proven reliability and on the supplier's ability to keep the equipment running for decades, not on lowest sticker price. That is what makes the product hard: it is the metallurgy, the hydraulic engineering, the precision machining, the qualification testing, and the decades of field data that let Flowserve guarantee a pump will run for years between failures in a duty that would destroy a generic pump in weeks.

A concrete example: a refinery commissioning a new crude unit needs a large engineered centrifugal pump to move heavy hydrocarbon at high temperature. Flowserve's engineers design the pump to the customer's exact hydraulic specification and metallurgy, build it, test it against API (American Petroleum Institute) standards, and ship it. It is installed with Flowserve mechanical seals that prevent the hydrocarbon escaping along the rotating shaft, and Flowserve control valves regulating flow downstream. Twenty years later, that same refinery is still buying seal replacements, impellers, and bearing kits from Flowserve, sending pumps to a local QRC for overhaul, and upgrading the hydraulics for efficiency. The original sale was competitive; the twenty-year tail is where the company makes its returns.

Flowserve in its current form was created in 1997 by merging Durco International and BW/IP International, with roots tracing back to the Duriron Company founded in 1912. It is headquartered in Irving, Texas. The relevant recent story, though, is operational: since CEO Scott Rowe arrived, and intensifying over the last three years, management has run a self-improvement program called the Flowserve Business System (FBS) - a Danaher-style operating discipline - with an "80/20" complexity-reduction effort (focus resources on the 20% of products and customers that drive 80% of value, prune the long tail). This has driven thirteen consecutive quarters of gross-margin expansion through Q1 2026, and it is the single most important thing happening at the company.

"We remain focused on driving growth while leveraging the Flowserve Business System to accelerate margin expansion." - Scott Rowe, CEO (Q3 2025 call, Oct 29 2025)

One more piece of recent corporate history matters. In June 2025 Flowserve announced an all-stock "merger of equals" with Chart Industries valued at roughly $19 billion. Six weeks later Baker Hughes made a superior $13.6 billion all-cash bid for Chart; Flowserve's board declined to raise its offer, and the merger was terminated on July 29, 2025. Flowserve walked away with a $266 million termination payment ($250M fee plus $16M expense reimbursement) and a multi-year supply agreement. Flowserve remains an independent, standalone company, and it deployed much of that cash into share buybacks and the pending Trillium Valves acquisition.

Section 2: Business Segments

Flowserve reports in two segments: the Flowserve Pumps Division (FPD) and the Flow Control Division (FCD). FPD is the larger and historically higher-margin business; FCD is the valve-and-actuation business that has been the bigger fixer-upper and the bigger margin-improvement story recently.

Flowserve Pumps Division (FPD)

FPD designs, makes, and services engineered and industrial pumps plus mechanical seals and sealing systems. This is the original heart of the company. The pumps range from large, custom-engineered centrifugal units built to a refinery's or power plant's exact duty, down to more standardized industrial pumps produced in higher volume. Critically, FPD also houses the mechanical seals business - the precision components that stop fluid escaping along a rotating pump or compressor shaft. Seals are a quiet jewel: they wear out and get replaced regularly, they are engineered to the specific fluid and duty, and they generate steady aftermarket pull-through.

The core capability here is hydraulic and metallurgical engineering combined with a vast installed base. Designing a pump that moves a specific fluid at a specific flow and pressure efficiently, and survives years of abrasion and corrosion, is decades of accumulated know-how. The aftermarket franchise is the moat: with millions of Flowserve pumps and seals installed globally, the recurring parts-and-service stream is large and sticky, because a customer running a Flowserve pump overwhelmingly buys Flowserve OEM parts to preserve warranty, reliability, and performance.

FPD is the group's margin engine. Management repeatedly describes it as operating "at margins similar to best-in-class industrials," with adjusted operating margin around 20% and reaching 20.3% in Q2 2025 (Q2 2025 call, Jul 30 2025) and 19.1% in Q1 2026 (Q1 2026 call). It is the cash generator and the proof case that FBS works.

"FPD is now operating at margins similar to best-in-class industrials, and yet we still see opportunities." - Amy Schwetz, CFO (Q2 2025 call, Jul 30 2025)

Competitively, FPD goes up against Sulzer, KSB, Ebara, ITT (Goulds), and Baker Hughes' pump operations in process pumps, and a wide field in industrial pumps. It wins on engineering pedigree, the breadth of its catalogue (more than 100 distinct pump models), and the QRC aftermarket network. Within FPD, an Industrial Pumps unit went through an aggressive 80/20 cleanup - a 45% SKU reduction with a 21% increase in key-customer bookings and a 150 bps gross-margin improvement (Q3 2025 call) - a textbook example of pruning complexity to grow profitably.

Flow Control Division (FCD)

FCD designs, makes, and services valves, actuators, and the instrumentation and controls that automate them: quarter-turn, rotary, linear, control, and severe-service valves, plus electric, hydraulic, and pneumatic actuators and positioners. Where pumps move fluid, valves control and isolate it. In a chemical plant or nuclear station, the valve population is enormous, and severe-service valves - those handling extreme pressure, temperature, erosion, or corrosion - are highly engineered, mission-critical, and command good margins.

FCD exists as a separate division because the technology, the engineering, the manufacturing, and to some extent the customer-buying process differ from rotating equipment. Valves are about precise flow control, tight shutoff, and material science under erosive conditions, rather than hydraulic pump design. The division has also been shaped by acquisition: Flowserve bought MOGAS Industries (severe-service valves for mining, power, and harsh duties) in 2024, and has signed to acquire Trillium Flow Technologies' Valves Division for $490 million in cash, expected to close mid-2026 (Q4 2025 call, Feb 6 2026; Q1 2026 call).

For most of the last two years FCD was the margin-improvement project. MOGAS initially diluted FCD margins by roughly 260 basis points (Q2 2025 call), there was a deliberately discontinued fabricated-modules business dragging into early 2026, and integration took time. By Q3 2025 management said MOGAS had turned accretive and was operating at peer-group margins, and FCD's adjusted operating margin expanded 230 bps year-over-year and 410 bps sequentially (Q3 2025 call). By Q1 2026 FCD operating margin hit 15.9%, up 370 bps, with gross margin up 480 bps - the steepest improvement in the company (Q1 2026 call). FCD has become the growth-and-self-help bet: large nuclear awards, strong book-to-bill (1.14x in Q1 2026), and the Trillium deal that deepens its position in nuclear and power valves.

Competitively FCD faces Emerson (Fisher valves), Baker Hughes (Valves, ex-Masoneilan/Mooney), Crane, Velan, IMI, and Weir in specific niches. It wins in severe-service and nuclear-qualified valves where the engineering and certification barriers are high.

Section 3: Products and Business Detail

Pumps. Flowserve offers more than 100 distinct pump models spanning centrifugal, positive-displacement, and specialty designs, built to international standards (API for oil and gas, ANSI/ISO for chemical, nuclear codes for power). At the top end are large engineered pumps custom-designed for a single duty - the multi-stage barrel pumps that pressurize crude in a refinery, boiler feed and reactor coolant pumps in power plants, and slurry pumps in mining. Below that sit industrial process pumps produced more repeatably. Pumps serve oil and gas, chemical processing, power generation, water resources, and general industry.

Valves and actuation. The valve catalogue covers quarter-turn, rotary, linear, control, and severe-service configurations, marketed for extended service life, safe operation, and emissions control (fugitive-emissions-tight valves are increasingly required by environmental regulation). Alongside the valves, Flowserve supplies the full automation stack: electronic positioners, level switches, and electric, hydraulic, and pneumatic actuators that open, close, and modulate valves remotely. Severe-service valves for nuclear, high-pressure power, and mining are the highest-value niche.

Mechanical seals. Drawing on more than 80 years of sealing expertise, Flowserve makes sealing systems for pumps, compressors, and turbines across oil and gas, pharmaceutical, chemical, and mineral processing. Seals are engineered to the specific fluid and duty, wear out, and get replaced - a steady recurring revenue stream tightly tied to the pump installed base.

Aftermarket and the QRC network. The aftermarket business - spare parts, repairs, overhauls, seal replacements, upgrades, and field service - is delivered through a global network of Quick Response Centers positioned near customers. The promise is speed: minimizing downtime on critical equipment, with seal orders inside 72 hours. Aftermarket is the most valuable part of the franchise: durable, higher-margin, and recurring, running above $600 million in quarterly bookings for eight straight quarters through Q1 2026.

Manufacturing and geography. Flowserve manufactures across more than 50 countries with a global footprint of plants and QRCs, selling into oil and gas, power, chemical, water, pharmaceuticals, food processing, and mining worldwide. The geographic spread is both a strength (local presence near customers, regional aftermarket) and a tariff exposure (cross-border component flows; management flagged tariffs as a 2025 second-half issue, with $90-100 million gross annualized impact pre-mitigation, weighted toward FCD - Q1 2025 call).

Operating system and growth strategy. Two frameworks run through everything management says. The Flowserve Business System (FBS) is the continuous-improvement operating model driving margin expansion; the "80/20" program prunes product and customer complexity to focus on what is profitable. The growth strategy is framed around "3D" - Diversification, Decarbonization, and Digitization - with decarbonization-linked awards (carbon capture, hydrogen, energy transition) representing 31% of total Q1 2025 awards (Q1 2025 call).

Recent acquisitions that reshaped the product set. MOGAS Industries (severe-service valves, into FCD, 2024) and the pending Trillium Flow Technologies Valves Division ($490M cash, mission-critical valves for nuclear and traditional power, expected to close mid-2026) both deepen FCD's severe-service and nuclear valve franchise.

Section 4: Customers

Flowserve sells to the operators of process-industry plants: oil and gas (upstream, midstream, and especially refining/petrochemical), chemical processing, power generation (fossil and increasingly nuclear), water and desalination, mining and minerals, pharmaceuticals, and general industry. Customers are the world's energy majors, national oil companies, chemical producers, utilities, EPC (engineering, procurement, construction) contractors who build plants on behalf of those owners, and mining houses. The customer base is geographically diversified across North America, the Middle East, Europe, Asia, and Latin America.

The buying decision differs by what is being bought. For original equipment on a new plant, the EPC contractor and the plant owner's engineering organization specify the equipment, and the criteria are technical compliance (does the pump meet the API hydraulic and reliability spec?), proven field reliability, delivery schedule against the construction timeline, total lifecycle cost, and increasingly emissions performance. Sales cycles for large engineered projects run many months to years, tracked through a project funnel that management sizes on every call. For aftermarket, the buyer is the plant's reliability and maintenance organization, the criteria are speed and OEM authenticity, and the cycle is short and recurring.

Customers choose Flowserve for specific reasons: a long track record of reliability in the exact duty, the engineering capability to design to a custom specification, the breadth to supply pumps, valves, and seals from one vendor, and - decisively for aftermarket - the QRC network that gets a failed unit back in service fast. The company stresses that the bar to displace it is high.

"Barriers to entry here are really, really high...quality plans and what our customers are looking for." - Scott Rowe, CEO (Q3 2025 call, Oct 29 2025)

Switching costs are real and structural. Once a Flowserve pump or valve is installed, the operator overwhelmingly buys Flowserve OEM parts and service for it - swapping to a third-party part risks warranty, reliability, and in regulated settings (nuclear) qualification. Requalifying a different OEM's equipment in a safety-critical or environmentally sensitive duty is expensive and slow. In nuclear specifically, Flowserve says it has roughly 75% content penetration in the 416 operating reactors globally (Q3 2025 call) - an installed-base position that compounds for decades because nuclear parts must be qualified to the specific reactor.

Concentration is low. Flowserve serves thousands of customers across many industries and geographies; no single customer dominates, which is a stabilizer - the diversification across oil and gas, chemical, power, water, and general industry is a deliberate part of the "3D" strategy and cushions any single end-market downturn. Contract structure is a mix: project-based OE bookings (lumpy, competitively bid, tracked via book-to-bill, which ran 1.07x in Q1 2026) plus a large recurring aftermarket book that gives revenue a predictable floor. Backlog sat near $2.9 billion through 2025, giving visibility into forward revenue.

Section 5: Competitive Landscape

The flow-control industry is fragmented but anchored by a handful of large, diversified players, with deep specialists in each niche. Flowserve is one of the broadest - it spans pumps, valves, and seals, where most rivals are strong in only one or two of those. No single firm dominates the combined pump-valve-seal market; the global pumps market alone is around $79 billion (Pumps Market global forecast, GlobeNewswire, Jan 2025), and the combined pumps-and-valves market is roughly $150-160 billion (2025), so even the largest players hold modest single-digit shares.

In pumps, Flowserve competes with Sulzer (Switzerland), KSB (Germany), Ebara (Japan), ITT/Goulds (US), Grundfos (private, Denmark, more water-focused), Xylem (US, water/wastewater), and Baker Hughes' pump operations. Flowserve and Sulzer are the closest peers in large engineered process pumps for oil, gas, and power. Flowserve wins on installed-base aftermarket and breadth; it can lose on price in commoditized industrial pumps and on regional presence where KSB or Ebara are entrenched.

In valves, the field includes Emerson (Fisher control valves - a formidable competitor), Baker Hughes (Valves, including the Masoneilan/Mooney/Consolidated lines), Crane, Velan, IMI, and Weir in severe-service niches. Emerson is the standout in control valves and process automation. Flowserve competes best in severe-service and nuclear-qualified valves, where MOGAS and the pending Trillium deal strengthen it.

In mechanical seals, the main rival is John Crane (part of Smiths Group, UK) and EagleBurgmann (a Freudenberg/EKK joint venture). This is a tight two-to-three-player oligopoly with very high engineering and qualification barriers.

Barriers to entry are genuinely high, especially in engineered and severe-service equipment: decades of field reliability data, metallurgical and hydraulic know-how, API/ANSI/nuclear certifications, the capital to build and test heavy equipment, and - the hardest to replicate - a global aftermarket service network sitting next to customer plants. A new entrant cannot manufacture trust in a duty where failure causes a fire. Where competition bites is in standardized, lower-spec industrial pumps and valves, which are more commoditized and price-competitive, and where regional low-cost manufacturers can win on price.

The structural shifts worth watching: consolidation (Baker Hughes buying Chart, Flowserve rolling up valve assets via MOGAS and Trillium), the nuclear renaissance creating a new high-barrier demand pool that favors incumbents with qualified content, and digitization/monitoring adding software-and-services revenue on top of hardware.

Market caps are approximate peer-size references with the noted as-of dates and move daily; figures marked "(approx)" are estimates for mid-2026. No market cap is shown for Flowserve itself per report rules.

Section 6: Industry

Demand for Flowserve's products is driven by industrial capital investment and by the maintenance needs of the existing installed base. On the OE side, demand follows the capex cycles of oil and gas, chemicals, power, water, and mining - new plants, expansions, and revamps. On the aftermarket side, demand is far steadier: any operating plant must maintain its pumps, valves, and seals regardless of where the capex cycle sits, which is why aftermarket is the ballast in Flowserve's revenue.

The market is large. The combined global pumps-and-valves market was roughly $151-163 billion in 2025, projected toward $210-230 billion by the early 2030s at low-to-mid single-digit CAGRs (~3-3.4%) (Pump & Valves Market global forecast, Research and Markets / Global Growth Insights, 2025). The global pumps market alone is around $79 billion (Pumps Market forecast, GlobeNewswire, Jan 2025). Nested inside that is a fast-growing nuclear pumps market, ~$2.8 billion in 2025 heading to ~$4.6 billion by 2034 (~5.7% CAGR) (Nuclear Pumps Market, Dataintelo, 2025) - the niche Flowserve is leaning into hardest.

Flowserve sits in the middle of the process-industry supply chain: it is a critical-component supplier to plant owners and to the EPC contractors that build their plants. Its equipment is a small fraction of total plant capex but a large fraction of plant reliability risk, which is why specification and qualification matter more than price.

The regulatory environment shapes demand in three ways. First, emissions and safety regulation (fugitive-emissions standards on valves and seals, environmental rules on leak prevention) pushes operators toward higher-spec, certified equipment - a tailwind for engineered suppliers. Second, nuclear regulation creates extremely high qualification barriers that protect incumbents like Flowserve with existing reactor content. Third, trade policy (tariffs) is a swing factor on cost: management quantified a $90-100 million gross annualized tariff headwind in 2025, mitigated through pricing, supply-chain repositioning, and 80/20 (Q1 2025 call).

Cyclicality is moderate and dampened by aftermarket. The OE book swings with energy and chemical capex - and within that, regional cycles matter: the Middle East energy-project pipeline hit a "five-year low" in 2025 with recovery expected in 2026 (Q3 2025 call), while power, driven by AI/data-center electricity demand and nuclear, has been a strong upcycle. The aftermarket's steadiness means Flowserve is less cyclical than a pure capital-goods name.

Industry tailwinds: the nuclear renaissance (new reactors plus small modular reactors), power demand from AI/data centers and electrification, energy security spending, decarbonization (carbon capture, hydrogen), and the long-cycle replacement of aging installed equipment. Industry headwinds: lumpy large-project timing, Middle East and oil-and-gas capex softness, tariff and supply-chain cost inflation, and price competition in commoditized product tiers.

Section 7: Growth Triggers

All triggers below are drawn from the five concall transcripts and cited to the call.

• Nuclear new-build and SMRs. Flowserve booked roughly $400 million of nuclear awards across full-year 2025, with $140 million in Q3 2025 (a record) and $110 million in Q1 2026. Management sizes a $10 billion-plus addressable nuclear opportunity over ten years at ~$100M of content per gigawatt, with ~40 large reactors and up to 30 SMRs in the pipeline over the next decade, and ~75% content penetration in the 416 operating reactors globally. (Q3 2025 call, Oct 29 2025; Q1 2026 call, May 9 2026) - repeated across all five calls.

"We did win our first commercial award for a small modular nuclear reactor...primary coolant pumps for SMR technology." - Scott Rowe (Q2 2025 call, Jul 30 2025)

• Trillium Valves acquisition closing mid-2026. $490 million cash deal for Trillium Flow Technologies' Valves Division, mission-critical valves for nuclear and traditional power, expected accretive to adjusted operating income in 2026. (Q4 2025 call, Feb 6 2026; Q1 2026 call) - new in Q4 2025, reaffirmed Q1 2026.

"We're even more excited today than we were two or three months ago about this acquisition." - Amy Schwetz, CFO (Q1 2026 call, May 9 2026)

• Power demand from AI, data centers, and electrification. Year-to-date power book-to-bill of 2.0x through Q3 2025; power bookings up 23% YoY in Q3 2025 and 45%+ in Q1 2025. (Q1 2025 call, Apr 30 2025; Q3 2025 call) - repeated.

• Aftermarket capture-rate gains on the installed base. Aftermarket bookings above $600 million for eight consecutive quarters through Q1 2026, reaching $680 million in Q1 2026, driven by capture-rate improvements. (Q1 2026 call) - repeated every call.

• Middle East energy-project recovery in 2026. The Middle East funnel was at a five-year low in 2025 with delayed projects expected to recover in 2026. (Q3 2025 call) - new emphasis Q3 2025.

• MOGAS integration turning from drag to growth in FCD. MOGAS moved from diluting FCD margin ~260 bps to accretive and at peer-group margins; the discontinued fabricated-modules drag runs off into early 2026, shifting focus to growth. (Q2 2025 call; Q3 2025 call) - progressed across Q2-Q3 2025.

• Continued margin expansion via the Flowserve Business System / 80/20. Thirteen consecutive quarters of gross-margin expansion through Q1 2026; segment operating-margin targets of 16-18% by 2027, with company operating margin already inside the 14-16% target ahead of plan. (Q3 2025 call; Q1 2026 call) - repeated.

Section 8: Key Risks

Large-project and end-market timing (lumpy OE bookings). Flowserve's OE book swings with customer capex, and large awards do not repeat smoothly. In Q2 2025 management noted two large Middle East awards (~$150M combined) did not repeat, and the Middle East funnel hit a five-year low (Q2/Q3 2025). Q1 2026 bookings fell 6% YoY (Q1 2026 call), and the stock fell on that print. The mechanism: a soft quarter of project awards directly compresses backlog and forward revenue. This is a high-probability, moderate-drag risk inherent to the capital-goods model, partly offset by aftermarket steadiness.

Tariffs and supply-chain cost inflation. Management quantified a $90-100 million gross annualized tariff headwind in 2025, weighted toward FCD, mitigated only partly (pricing offsets ~50%) (Q1 2025 call). If tariffs escalate or mitigation lags, margins compress. Moderate probability, moderate magnitude, and an ongoing live exposure given the global manufacturing footprint.

"tariff impact and exposure is greater on the FCD side of the business." - Amy Schwetz (Q1 2025 call, Apr 30 2025)

Integration and M&A execution. The MOGAS integration diluted FCD margins ~260 bps and dragged for several quarters before turning accretive (Q2-Q3 2025). The pending $490M Trillium deal carries the same risk: if integration runs long or synergies disappoint, the accretion thesis slips. Moderate probability given the company's recent integration track record improving, but the larger the deal, the larger the downside if it goes wrong.

Oil-and-gas and chemical capex cyclicality. A meaningful share of FPD/FCD OE demand still rides on energy and chemical investment. A sustained downturn in oil-and-gas capex (low oil prices, energy-transition capital reallocation) would shrink the project funnel. Lower-probability-in-the-near-term given the current power/nuclear upcycle, but the structural exposure remains.

Concentration of the bull thesis in nuclear. Much of the growth narrative now rests on nuclear new-build and SMRs. Nuclear projects are notoriously prone to delay, cost overruns, and cancellation; SMR commercialization timelines could slip years. If the nuclear renaissance underdelivers, a central growth pillar weakens. Low-to-moderate probability of total failure, but timing risk is high.

Margin-expansion runway maturing. Thirteen straight quarters of gross-margin expansion is impressive but mathematically cannot continue indefinitely; FPD is already at best-in-class ~20% operating margin. As the easy 80/20 wins are harvested, incremental margin gains get harder, and the market has priced in continued expansion. The risk is not a collapse but a deceleration that disappoints expectations.

Section 9: Walk the Talk

Five calls used: Q1 2025 (Apr 30 2025), Q2 2025 (Jul 30 2025), Q3 2025 (Oct 29 2025), Q4/FY 2025 (Feb 6 2026), Q1 2026 (May 9 2026). The most recent is within 90 days of today.

The dominant theme across these five calls is a management team that under-promised on earnings and then raised the bar, while delivering relentlessly on margins. The pattern is consistent and credible.

Start with Q1 2025. Management reaffirmed full-year 2025 guidance of adjusted EPS $3.10-$3.30 with 3-5% organic growth and ~100 bps of operating-margin expansion, and flagged a $90-100M tariff headwind as a second-half issue (Q1 2025 call). That was a steady, slightly cautious opening.

"we have a number of levers in place to mitigate the impact of the current tariff program." - Scott Rowe (Q1 2025 call)

By Q2 2025, management raised the full-year EPS guide to $3.25-$3.40, explicitly more than 25% YoY growth at the midpoint, even as they trimmed organic growth to 3-4%.

"we increased our full year adjusted EPS guidance to $3.25 to $3.40, which at the midpoint represents an increase of more than 25% year-over-year." - Scott Rowe (Q2 2025 call)

By Q3 2025 they raised again to $3.40-$3.50 - the second raise of the year - representing roughly 31% YoY growth, and noted they had already reached the 14-16% operating-margin target ahead of the 2027 timeline (Q3 2025 call). Then the actual full-year 2025 result, reported in Q4, came in at adjusted EPS of $3.64 - above the top of even the twice-raised guidance range, with adjusted operating margin expanding to 14.8% from 11.8% (Q4 2025 call, Feb 6 2026). Management guided to $3.10-$3.30 in April and delivered $3.64. That is a clean beat-and-raise sequence, not optimism that fell short.

The margin story is the strongest "walk the talk" evidence. Management said FBS and 80/20 would drive sustained margin expansion, and the company posted thirteen consecutive quarters of gross-margin expansion through Q1 2026, hit its 14-16% operating-margin target years ahead of the 2027 plan, and dragged FCD from a MOGAS-diluted laggard to a 15.9% operating-margin division (Q1 2026 call). The MOGAS turnaround specifically tracked exactly as promised: management said in Q2 2025 that synergy realization was "right on track" to overcome the dilution, and by Q3 2025 MOGAS was accretive and at peer margins. Promise made, promise kept.

"synergy realization, which we've needed to overcome some of these issues is right on track." - Amy Schwetz (Q2 2025 call)

The capital-allocation discipline around the Chart merger also reflects credibility. Rather than chase a deal at a value-diminishing price, management walked, took the $266M fee, and redeployed it into buybacks and Trillium - and said so plainly.

"further pursuing the merger would have been value diminishing to Flowserve shareholders given the additional cash, leverage and diluted ownership required." - Scott Rowe (Q2 2025 call)

Where the picture is less flattering is on bookings, and management has been honest about it rather than spinning it. Organic growth guidance was trimmed from 3-5% to 3-4% during 2025; the Middle East funnel weakness was disclosed, not buried; and Q1 2026 bookings were down 6% YoY, which management acknowledged while maintaining the full-year EPS guide of $4.00-$4.20 and calling mid-single-digit bookings growth "achievable" rather than guaranteed (Q1 2026 call). That is a team that lets the top line breathe honestly while controlling what it can control - cost and margin.

Net assessment: this is management that does what it says, and on earnings and margins has consistently done better than it said. The earnings beats were real, the margin program delivered ahead of schedule, the MOGAS integration tracked to plan, and the Chart decision showed capital discipline. The one area of genuine uncertainty - lumpy bookings and the Middle East/Q1 2026 softness - has been disclosed candidly rather than dressed up. On balance, high credibility.

Section 10: Shareholder Friendliness Index

Dividends. Flowserve has paid a dividend for more than 19 consecutive years and has raised it modestly each of the last three years: $0.80 per share in 2023 ($0.20/quarter), $0.84 in 2024 ($0.21/quarter), and $0.88 in 2025 ($0.22/quarter), with the $0.22 quarterly rate continuing into 2026 (Flowserve dividend history, stockanalysis.com; company 8-K filings). Growth has been steady but small - roughly 5% then ~4.8% - so the dividend is a reliable, low-yield, slowly-growing component rather than the main return vehicle. Payout is comfortable against rising earnings (adjusted EPS reached $3.64 in 2025), so the dividend is well covered and the modest growth reflects a deliberate bias toward buybacks and M&A rather than any constraint.

Buybacks and dilution. The MoatMap database recorded zero buyback disclosures in the trailing ~90 days (since 2026-03-15), which only means nothing was logged in that short window, not that the company does not repurchase. The three-year external picture is the real story: buybacks were minimal in 2023 (~$20M) and 2024 (~$16M), then stepped up dramatically in 2025. Through October 2025 the company had repurchased $253M year-to-date ($145M in Q3 2025 alone), and full-year 2025 returned $365M to shareholders via dividends and buybacks combined - implying roughly $250M+ of buybacks in 2025, funded substantially by the $266M Chart termination fee (Q3 2025 call; Q4 2025 results, Feb 6 2026). The board replenished the repurchase authorization to $300M. Management was explicit that it viewed the shares as undervalued.

"we view our share price at a discount to its intrinsic value." - Amy Schwetz (Q1 2025 call)

Share count has been roughly flat over the three years - option dilution broadly offset modest buybacks in 2023-2024, with the larger 2025 program beginning to bend the count down. So the buyback is real and accelerating but has not yet meaningfully shrunk the float.

Verdict: Returns Capital (rising) - a long-standing, steadily-growing dividend plus a buyback program that stepped up sharply in 2025 and is being run opportunistically against a stated undervaluation view, alongside disciplined M&A rather than empire-building.

Section 11: Insider Activities

Source: MoatMap US insider database (built on SEC Form 4), used as the spine, cross-checked against the most recent two weeks. The window covers the last 12 months; all dated 2026 because that is where the activity clustered. Eleven transactions, five distinct insiders, two open-market buys, zero open-market sells, nine "other" (grants/deferred-comp).

Buys - read the signal. Two directors made open-market purchases in mid-May 2026, immediately after the Q1 2026 results (May 9) sent the stock lower - Brian Savoy bought 1,000 shares at $67.34 on May 14, and Michael McMurray bought 2,500 shares at $65.71 on May 18 (Form 4). This is cluster buying by two board members in the same one-week window, on the dip, by financially sophisticated insiders (McMurray is a former Flowserve CFO; the directors here sit on the audit/finance side). The purchases coincided with the same window in which both also received their routine annual director equity grants (the 2,573-share "Other" lines on May 14), but the open-market cash purchases are separate and discretionary - directors do not have to spend their own money on top of a grant unless they want more exposure. The combination of two independent directors buying on the dip in the same week is a bullish signal. It is not a CEO/CFO mega-buy, so I would not over-weight it, but cluster director buying after a sell-off is a meaningful vote of confidence.

Sells - work out the why. There were no open-market sells in the 12-month window. Nothing to explain.

The "Other" rows. The small monthly 31-61 share accruals by CEO Rowe and CLO Hudson on the 1st of April, May, and June are routine deferred-compensation or dividend-reinvestment style accruals, not market signals. The 2,573-share May 14 lines for Okray, McMurray, and Savoy are the annual non-employee-director equity retainer (identical share counts at the same price = a formulaic grant), again not a discretionary signal.

Net assessment. Insiders were net buyers over the window, with zero sells. Activity is concentrated in the board rather than the C-suite, but the signal that matters - two directors buying with their own cash on the post-earnings dip in the same week - is constructive. There is no CEO or CFO open-market purchase to elevate this to "very bullish," and the CEO's only activity was routine sub-100-share accruals, so I read the overall picture as a mild bullish signal: clean (no selling), directionally positive (cluster director buying on weakness), but not a conviction-defining insider event.

Section 12: Scenarios

Bull case. The nuclear renaissance arrives on schedule and Flowserve's ~75% content position in the existing reactor fleet converts into a dominant share of new-build and SMR awards, layering a multi-billion-dollar, decade-long high-margin demand pool on top of the base business. Power demand from AI data centers and electrification keeps the power book-to-bill running hot, the Middle East project funnel recovers in 2026 as management expects, and the Trillium acquisition closes smoothly and slots into FCD as cleanly as MOGAS eventually did - deepening the severe-service valve franchise right as nuclear and power valve demand peaks. The Flowserve Business System keeps grinding out margin, FCD converges toward FPD's best-in-class profitability, and the aftermarket installed base compounds quietly underneath it all. Management keeps beating its own guidance, redeploys strong free cash flow into buybacks at prices it considers cheap, and the company is re-rated as a disciplined, nuclear-levered industrial compounder rather than a cyclical pump maker.

Base case. Management delivers roughly what it has guided: full-year 2026 adjusted EPS in the $4.00-$4.20 range, total sales up mid-single digits with help from acquisitions, and continued operating-margin expansion of around 100 bps. Bookings stay lumpy - some soft quarters like Q1 2026, offset by nuclear and power strength - and net out around a 1.0x book-to-bill, keeping backlog stable near record levels. Trillium closes mid-2026 and is modestly accretive. The aftermarket franchise keeps printing $600M-plus quarters. The dividend rises another low-single-digit step and the buyback continues at a measured pace. Nothing breaks, nothing dramatically surprises; the business keeps doing what it has done for the last two years - steady earnings growth driven more by self-help margin and capital allocation than by a booming top line.

Bear case. The bookings softness that showed up in Q1 2026 turns out to be the leading edge of a broader capex slowdown rather than noise. Oil-and-gas and chemical investment retrenches, the Middle East recovery keeps slipping, and the nuclear pipeline - always prone to delay and cancellation - underdelivers on timing, leaving the central growth narrative stranded. The Trillium integration runs long and dilutes FCD margins the way MOGAS did at first, but this time without a clean recovery, and tariff costs outrun the company's ability to price them through. The thirteen-quarter margin-expansion streak matures and decelerates just as the market has fully priced continued gains, so even in-line operations disappoint. Backlog erodes, the aftermarket ballast cushions but cannot offset a shrinking OE book, and a company that had been re-rated on execution gives some of that back as the cyclical reality of capital goods reasserts itself.

Note on chart data: segment mix, OE/aftermarket split, and the FY2023-2024 EPS/return figures are directional approximations assembled from the cited calls and filings; FY2025 figures and the FY2026 guidance midpoint are as reported. Treat the directional bars as scale indicators, not audited values.

Sources:

• Flowserve Q1 2026 earnings call transcript (May 9 2026) - Investing.com
• Flowserve Q4/FY2025 results 8-K press release - SEC EDGAR
• Flowserve Q3 2025 earnings call transcript (Oct 29 2025) - Insider Monkey
• Flowserve Q2 2025 earnings call transcript (Jul 30 2025) - Insider Monkey
• Flowserve Q1 2025 earnings call transcript (Apr 30 2025) - Investing.com
• Chart Industries & Flowserve merger of equals announcement (Jun 2025) - Flowserve IR
• Flowserve terminates Chart Industries merger, $266M fee (Jul 29 2025) - MLex
• Flowserve posts strong 2025 results, announces Trillium Valves deal - Globe and Mail
• Flowserve products overview - flowserve.com
• Flowserve (FLS) dividend history - stockanalysis.com
• Pumps Market global forecast ($79B; Grundfos, Xylem, Flowserve, KSB, Sulzer) - GlobeNewswire, Jan 2025
• Pump & Valves Market global forecast 2025-2032 - Research and Markets
• Nuclear Pumps Market report - Dataintelo
• Baker Hughes market cap - companiesmarketcap.com
• Xylem market cap - companiesmarketcap.com

A note on completeness: all five required earnings calls were located and used (Q1 2025 through Q1 2026), with the most recent within 35 days. Section 13 (Further Reading) is intentionally omitted - SemiAnalysis, Stratechery, and MBI Deep Dives have no qualifying coverage of Flowserve, which is consistent with their tech/semiconductor/consumer-equity focus.